Quest Magazine

News: Isis Pharmaceuticals Reports Data from Phase 2 Study in Infants with Spinal Muscular Atrophy

It's Myasthenia Gravis Awareness Month 2015

In recognition of June being National Myasthenia Gravis Awareness Month, MDA is examining the disease from several perspectives. This article offers an overview of signs, symptoms, diagnosis and treatments for myasthenia gravis (MG), as well as information on drugs that people with MG should avoid.

FDA issues draft guidance on developing drugs for Duchenne Muscular Dystrophy

FDA Approves Investigational New Drug Application for ALS Cellular Therapy

Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum

National Endurance Program Actively Recruiting Participants for
 Signature Half / Full Marathon Events this Fall

Large-scale discovery of DMD biomarkers

MDA Summer Camp Celebrates 60 Years of Changing Lives


Sarepta Announces Plans to Submit Rolling NDA for Treatment of Duchenne Muscular Dystrophy

28th Annual MDA Ride for Life Raises More Than $1.1 Million to Fuel the Fight Against Muscle Disease

PHILADELPHA, May 11, 2015 — Opening weekend at Camelback Lodge and Indoor Waterpark helped bring huge success to the 28th annual MDA Ride for Life event held on May 1-3, which raised more than $1.1 million to benefit families affected by muscular dystrophy and related life-threatening diseases.

Always Forward for our Families

By Steven M. Derks, MDA President and CEO


MDA’s mission is life-changing. Steadfast and malleable, it reminds us to never forget where we have come from – we were started by families, for families – as we meet the evolving needs and opportunities of the day.